Hamilton, Canada

Probal Kanti Datta

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Brantford, CA (2010 - 2013)
  • Hamilton, CA (2010 - 2018)

Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Probal Kanti Datta: Innovator in Pharmaceutical Chemistry

Introduction

Probal Kanti Datta is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid forms of nilotinib hydrochloride. With a total of 6 patents to his name, Datta's work has had a substantial impact on the treatment of chronic myelogenous leukemia (CML).

Latest Patents

Datta's latest patents include innovative formulations of nilotinib hydrochloride. One of his notable inventions is a solid form of nilotinib hydrochloride, which exists as a co-crystal with levulinic acid in a molar ratio of 1:2. This co-crystal is significant for its potential applications in improving the solubility and bioavailability of the drug. Additionally, he has disclosed various crystalline solvates of nilotinib hydrochloride, including those with benzyl alcohol, acetic acid, propylene glycol, and isopropanol. These formulations are crucial as nilotinib HCl is a tyrosine kinase inhibitor used for treating drug-resistant CML.

Career Highlights

Throughout his career, Probal Kanti Datta has worked with prominent companies in the pharmaceutical industry, including Apotex Pharmachem Inc. and Apotex Inc. His expertise in drug formulation and development has positioned him as a key player in the advancement of cancer therapies.

Collaborations

Datta has collaborated with esteemed colleagues such as Allan W Rey and David A Stradiotto. These partnerships have fostered innovation and have contributed to the successful development of his patented formulations.

Conclusion

Probal Kanti Datta's contributions to pharmaceutical chemistry, particularly in the area of nilotinib hydrochloride, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment, showcasing the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…